Have you dreamed of owning a residential property and to live by the sea, for years? Are you looking for investment options in tourist area land that will offer high short- or long-term returns? Are ...

Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2023 Earnings Call Transcript April 10, 2024 Altamira Therapeutics Ltd. isn't one of the 30 most popular stocks among hedge funds at the end of the ...

Detailed price information for Altamira Gold Corp (ALTA-X) from The Globe and Mail including charting and trades.

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that ...

Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal ; Study met primary efficacy endpoint of improvement in nasa ...

The social and environmental impact of the Belo Monte dam and hydroelectric power plant in Pará state, Brazil, has been ...

“We are thrilled to see the detailed results from our pivotal Australian trial published in one the leading medical journals in allergology,” commented Thomas Meyer, Altamira’s ...

Altamira Therapeutics (CYTO) shares surge as positive results from the NASAR trial of their Bentrio nasal spray for allergic rhinitis are published.

HAMILTON, BERMUDA -- April 24, 2024 --Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and ...

Good morning, and welcome to the Altamira Therapeutics Business Update and Full Year 2023 Earnings Conference Call. On today's call are Thomas Meyer, Altamira's Founder, Chairman and the Chief ...

Altamira Therapeutics Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Altamira ...